购物车
- 全部删除
- 您的购物车当前为空
LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors.
LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 18,300 | 10-14周 | |
50 mg | ¥ 24,300 | 10-14周 | |
100 mg | ¥ 31,500 | 10-14周 |
产品描述 | LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors. |
分子量 | 603.55 |
分子式 | C29H32F2N3O7P |
CAS No. | 1258595-14-0 |
密度 | 1.414 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | 1M NaOH: 50 mg/mL (82.84 mM), when pH is adjusted to 12 with NaOH. Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容